Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Int J Mol Sci ; 22(11)2021 May 26.
Artigo em Inglês | MEDLINE | ID: mdl-34073521

RESUMO

In this study, we investigated the effect of mTOR inhibitor (mTORi) drug-eluting biodegradable stent (DE stent), a putative restenosis-inhibiting device for coronary artery, on thermal-injury-related ureteral stricture in rabbits. In vitro evaluation confirmed the dose-dependent effect of mTORi, i.e., rapamycin, on fibrotic markers in ureteral component cell lines. Upper ureteral fibrosis was induced by ureteral thermal injury in open surgery, which was followed by insertion of biodegradable stents, with or without rapamycin drug-eluting. Immunohistochemistry and Western blotting were performed 4 weeks after the operation to determine gross anatomy changes, collagen deposition, expression of epithelial-mesenchymal transition markers, including Smad, α-SMA, and SNAI 1. Ureteral thermal injury resulted in severe ipsilateral hydronephrosis. The levels of type III collagen, Smad, α-SMA, and SNAI 1 were increased 28 days after ureteral thermal injury. Treatment with mTORi-eluting biodegradable stents significantly attenuated thermal injury-induced urinary tract obstruction and reduced the level of fibrosis proteins, i.e., type III collagen. TGF-ß and EMT signaling pathway markers, Smad and SNAI 1, were significantly modified in DE stent-treated thermal-injury-related ureteral stricture rabbits. These results suggested that intra-ureteral administration of rapamycin by DE stent provides modification of fibrosis signaling pathway, and inhibiting mTOR may result in fibrotic process change.


Assuntos
Implantes Absorvíveis , Stents Farmacológicos , Sirolimo , Serina-Treonina Quinases TOR/antagonistas & inibidores , Obstrução Ureteral , Animais , Fibrose , Coelhos , Sirolimo/química , Sirolimo/farmacologia , Serina-Treonina Quinases TOR/metabolismo , Obstrução Ureteral/metabolismo , Obstrução Ureteral/patologia , Obstrução Ureteral/terapia
2.
Catheter Cardiovasc Interv ; 80(3): 429-36, 2012 Sep 01.
Artigo em Inglês | MEDLINE | ID: mdl-22105925

RESUMO

OBJECTIVES: To evaluate the effect of a polymer-free Biolimus A9-eluting stent [BioFreedom (BF)], compared with that of a biodegradable polymer-based Biolimus A9-eluting stent [BioMatrix Flex (BMF)] and a bare metal stent (BMS) in balloon denuded and radiated hypercholesterolemic rabbit iliac arteries. METHODS: Rabbits were fed with 1% cholesterol diet (n = 14) for 14 days, both iliac arteries were balloon denuded and radiated, and then rabbits were switched to 0.15% cholesterol diet. After 4 weeks, BF (n = 8), BMF (n = 8), and BMS (n = 8) were deployed in denuded and radiated areas. Four weeks later animals were euthanized, arterial segments were processed for morphometry. RESULTS: The neointimal area in vessels implanted with BF stents was significantly less than that seen in vessels implanted with BMS (0.90 mm(2) ± 0.14 vs. 1.29 mm(2) ± 0.23, P <0.01). Percent fibrin and fibrin score were higher with BMF stents compared to BMS (P <0.03 and <0.04) and giant cell number was significantly higher with both BMF and BF stents (P < 0.01 for both). Percent endothelialization was significantly higher and % uncovered struts were lower with BMS compared to either BMF or BF stents (P < 0.05 for both). CONCLUSION: This study demonstrates that compared to BMS, BF stents significantly decreased neointimal hyperplasia.


Assuntos
Implantes Absorvíveis , Angioplastia com Balão/instrumentação , Aterosclerose/terapia , Fármacos Cardiovasculares/administração & dosagem , Stents Farmacológicos , Hipercolesterolemia/complicações , Artéria Ilíaca/patologia , Metais , Polímeros , Sirolimo/análogos & derivados , Stents , Animais , Aterosclerose/etiologia , Aterosclerose/metabolismo , Aterosclerose/patologia , Constrição Patológica , Modelos Animais de Doenças , Fibrina/metabolismo , Hiperplasia , Artéria Ilíaca/metabolismo , Artéria Ilíaca/efeitos da radiação , Inflamação/patologia , Masculino , Neointima , Placa Aterosclerótica , Desenho de Prótese , Coelhos , Sirolimo/administração & dosagem , Fatores de Tempo
3.
EuroIntervention ; 7(7): 835-43, 2011 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-22082579

RESUMO

AIMS: The objective of this study was to investigate the structural integrity and early vascular response of a polylactic acid-coated (i.e., biodegradable polymer) coronary drug-eluting stent (DES) (BioMatrix™; Biosensors International, Singapore) to three currently marketed FDA/CE- mark approved non-erodible polymer-coated DES in a porcine model. METHODS AND RESULTS: BioMatrix™, XIENCE V™ (Abbott Vascular, Santa Clara, CA, USA), TAXUS® Liberté™ (Boston Scientific, Natick, MA, USA), and Cypher SELECT™ (Cordis, Johnson & Johnson, Miami, FL, USA) stents were implanted in pig coronaries for seven days. Polymer integrity was assessed by scanning electron microscopy (SEM) following tissue digestion. In vitro expansion of the BioMatrix™ was also performed. SEM analysis of in vivo stents demonstrated polymer defects on the abluminal surface of all DES including polymer cracking (BioMatrix™), bridging (TAXUS Liberté™), round-small defects (Cypher SELECT™), and flaking (XIENCE V™). Histologically, the myocardium revealed no evidence of acute myocardial infarction or microscopic scarring, moreover all intramyocardial vessels were found to be patent with no evidence of emboli. In vitro results demonstrated greater BioMatrix™ polymer cracking and lifting. CONCLUSIONS: These results illustrate the presence of polymer defects in all DES (TAXUS Liberté™, Cypher SELECT™, XIENCE V™, BioMatrix™) implanted seven-days in pigs, with absence of myocardial damage in this small number of samples. Polymer coating irregularity was greater in BioMatrix™ stent expanded in vitro as compared to in vivo, suggesting simulated benchtop deployment induces greater damage to the biodegradable polymer coating than in vivo deployment in healthy porcine coronary arteries.


Assuntos
Implantes Absorvíveis , Angioplastia Coronária com Balão/instrumentação , Stents Farmacológicos , Ácido Láctico/química , Polímeros/química , Angioplastia Coronária com Balão/efeitos adversos , Animais , Vasos Coronários/patologia , Teste de Materiais , Microscopia Eletrônica de Varredura , Modelos Animais , Miocárdio/patologia , Poliésteres , Desenho de Prótese , Falha de Prótese , Propriedades de Superfície , Sus scrofa , Fatores de Tempo
4.
Circ Cardiovasc Interv ; 3(2): 174-83, 2010 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-20407114

RESUMO

BACKGROUND: Drug-eluting stents effectively reduce restenosis but may increase late thrombosis and delayed restenosis. Persistent polymer, the drug, or a combination of both could be responsible. Local delivery of Biolimus A9, a rapamycin derivative, from a polymer-free BioFreedom stent (Biosensors International) may prevent these complications. METHODS AND RESULTS: We compared high-dose (HD) (225 microg/14 mm Biolimus A9) and low-dose (LD) (112 microg/14 mm Biolimus A9) BioFreedom stents with a polymer-coated sirolimus-eluting Cypher stent (SES) and a bare-metal stent (BMS) at 28 days and 180 days in an overstretch coronary mini-swine model with histomorphometric and histological analysis. At 28 days, there was a reduction in neointimal proliferation by HD, LD, and SES compared with BMS (neointimal thickness: HD, 0.080+/-0.032; LD, 0.085+/-0.038; SES, 0.064+/-0.037; BMS, 0.19+/-0.111 mm; P<0.001; BMS > HD/LD/SES). At 180 days, both BioFreedom stents were associated with reduced neointimal proliferation, whereas SES exhibited increased neointima (neointimal thickness: HD, 0.12+/-0.034; LD, 0.10+/-0.040; SES, 0.20+/-0.111; BMS, 0.17+/-0.099 mm; P<0.001; SES > HD/LD; BMS > LD). At 180 days, BioFreedom stents showed decreased fibrin and inflammation, including granuloma and giant cells, compared with SES. CONCLUSIONS: The polymer-free Biolimus A9-coated stent demonstrates equivalent early and superior late reduction of intimal proliferation compared with SES in a porcine model. After implantation of BioFreedom stent, delayed arterial healing was minimal, and there was no increased inflammation at 180 days compared with SES implantation. The use of polymer-free stents may have a potential long-term benefit over traditional polymeric-coated drug-eluting stents.


Assuntos
Reestenose Coronária/terapia , Stents Farmacológicos , Células Gigantes/efeitos dos fármacos , Sirolimo/administração & dosagem , Túnica Íntima/efeitos dos fármacos , Animais , Proliferação de Células/efeitos dos fármacos , Fibrina/metabolismo , Células Gigantes/patologia , Granuloma , Inflamação , Sirolimo/análogos & derivados , Suínos , Porco Miniatura , Túnica Íntima/crescimento & desenvolvimento , Túnica Íntima/patologia , Túnica Íntima/cirurgia , Cicatrização/efeitos dos fármacos
5.
J Biomed Mater Res A ; 82(2): 492-7, 2007 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-17295256

RESUMO

Although many biodegradable polymers, such as poly-L-lactic acid and poly-L-glycolic acid, are preferentially composed of biological residues normally present in the human body, implants made of these materials often trigger inflammatory and fibrotic responses. Unfortunately, the mechanisms involved in degradable material-mediated tissue responses remain largely unknown. Using animal implantation and cell culture system models, we found a strong correlation between the rate of material degradation and the degree of inflammatory response to material implants. Furthermore, we have identified that both water-soluble and water-insoluble degradation products are potent triggers of phagocyte activation, including at the least, superoxide production. These results support a new concept that slow degradation may improve the biocompatibility of degradable drug-releasing particles and tissue engineering scaffolds.


Assuntos
Materiais Biocompatíveis/farmacologia , Ácido Láctico/farmacologia , Fagócitos/efeitos dos fármacos , Fagócitos/fisiologia , Polietilenoglicóis/farmacologia , Polímeros/farmacologia , Animais , Humanos , Técnicas In Vitro , Inflamação/etiologia , Inflamação/patologia , Masculino , Teste de Materiais , Camundongos , Fagócitos/patologia , Poliésteres , Próteses e Implantes/efeitos adversos , Superóxidos/metabolismo
6.
Biotechnol Prog ; 22(1): 38-44, 2006.
Artigo em Inglês | MEDLINE | ID: mdl-16454490

RESUMO

Biodegradable polymers including poly(l-lactic acid) (PLLA) have been used to develop cardiovascular prostheses such as vascular grafts and stents. However, implant-associated thrombosis, inflammation, and restenosis are still major obstacles for the utility of these devices. The lack of an endothelial cell (EC) lining (endothelialization) on the implants and the responses of the immune systems toward the implants have been associated with these complications. In our research strategy, we have combined the drug delivery principle with the strategies of tissue engineering, the controlled release of anti-inflammation drugs and enhanced endothelialization, to reduce the implant-associated adverse responses. We first integrated curcumin, an anti-inflammatory drug and anti-smooth muscle cell (SMC) proliferative drug, with PLLA. This curcumin-loaded PLLA material was then modified using adsorptive coating of adhesive proteins such as fibronectin, collagen-I, vitronectin, laminin, and matrigel to improve the endothelial cell (EC) adhesion and proliferation, and ECs were seeded on top of these modified surfaces. Our results showed steady drug release kinetics over the period of 50 days from curcumin-loaded PLLA materials. Additionally, integration of curcumin in PLLA increased the roughness of the scaffold at the nanometric scale using an atomic force microscopic analysis. Moreover, coating with fibronectin on curcumin-loaded PLLA surfaces gave the highest EC adhesion and proliferation compared to other adhesive proteins using PicoGreen DNA assays. The ability of our strategy to release the curcumin for producing anti-inflammation and anti-proliferation responses and to improve EC adhesion and growth after EC seeding suggests this strategy may reduce implant-associated adverse responses and be a better approach for vascular tissue engineering applications.


Assuntos
Materiais Biocompatíveis/química , Reestenose Coronária/prevenção & controle , Curcumina/farmacologia , Ácido Láctico/química , Polímeros/química , Engenharia Tecidual/métodos , Adesão Celular , Proliferação de Células , Células Cultivadas , Células Endoteliais/metabolismo , Células Endoteliais/ultraestrutura , Humanos , Poliésteres , Propriedades de Superfície
7.
J Biomater Sci Polym Ed ; 16(3): 353-70, 2005.
Artigo em Inglês | MEDLINE | ID: mdl-15850289

RESUMO

We investigated poly(L-lactic acid) (PLLA) fibers and coils, simulating stents and the influence of impregnation with curcumin, a non-steroidal anti-inflammatory drug, intended to reduce the pro-inflammatory property of these implants. Fibers obtained by melt extrusion of 137 kDa PLLA resin containing 10% curcumin (C-PLLA) exhibited a stable curcumin release rate for periods up to 36 days. Curcumin increased the fiber tensile strength at break and decreased embrittlement vs. controls in 36 day 37 degrees C saline incubation. A mouse peritoneal phagocyte model was employed to test the anti-inflammatory properties of C-PLLA fibers in vitro. Myeloperoxidase and non-specific esterase activity assays were performed for adherent cells (polymorphonuclear leukocytes (PMN) and macrophages (MPhi), respectively). PMN and MPhi adhesion to C-PLLA fibers were significantly reduced compared to control PLLA fibers (2.6 +/- 0.91) x 10(5) vs. (5.6 +/- 0.67) x 10(5) PMN/cm2 and (3.9 +/- 0.23) x 10(3) vs. (9.1 +/- 0.7) x 10(3) MPhi/cm2 (P < 0.05), respectively. In addition, superoxide release in the phagocyte pool contacting C-PLLA fibers was 97% less than that for PLLA controls. A fresh human whole blood recirculation system was employed to analyze cell adhesion under flow conditions, employing scanning electron microscopy (SEM). Reduced adhesion of cells on C-PLLA fiber coils vs. controls was observed. These in vitro studies demonstrate that bulk curcumin impregnation can reduce the inflammatory response to bioresorbable PLLA fibers, whilst improving mechanical properties, thereby suggesting curcumin loading may benefit PLLA-based implants.


Assuntos
Curcumina/química , Curcumina/farmacologia , Inflamação/induzido quimicamente , Ácido Láctico/química , Polímeros/química , Animais , Anti-Inflamatórios/farmacologia , Anti-Inflamatórios não Esteroides/farmacologia , Materiais Biocompatíveis/química , Adesão Celular , Citometria de Fluxo , Humanos , Macrófagos/metabolismo , Teste de Materiais , Camundongos , Microscopia Eletrônica de Varredura , Neutrófilos/metabolismo , Peritônio/citologia , Peroxidase/metabolismo , Fagócitos/metabolismo , Poliésteres , Superóxidos/metabolismo , Propriedades de Superfície , Temperatura , Resistência à Tração , Fatores de Tempo
8.
Biomaterials ; 25(23): 5333-46, 2004 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-15130718

RESUMO

A major complication of coronary stenting is restenosis, often accompanied by inflammatory reactions and smooth muscle cell proliferation. Curcumin has been shown to possess anti-inflammatory and anti-proliferative properties, thus we hypothesize that locally released curcumin by coronary stent would diminish in-stent restenosis. As a first test of this hypothesis, curcumin-eluting PLLA films (C-PLLA) were produced and the anti-inflammatory and anti-proliferative properties were then tested using peritoneal phagocytes and human coronary artery smooth muscle cell (hCASMCs) culture systems. We find that the addition of curcumin reduced phagocyte accumulation and activation on C-PLLA films. On the other hand, C-PLLA significantly reduced the proliferation, but not the adhesion, of hCASMCs. The molecular responses of hCASMCs to C-PLLA were further assessed by cDNA microarray analysis. Curcumin up-regulated genes related to apoptosis and enhanced the expression of anti-proliferative and anti-inflammatory factors, and of antioxidants. Equally important, C-PLLA inhibited the cell cycle progression of adherent hCASMCs. The results suggest that curcumin regulates gene expression and cell function through the protein kinase (PK) and mitogen-activated protein kinase (MAPK) pathways. These results support the use of curcumin to inhibit in-stent restenosis.


Assuntos
Implantes Absorvíveis , Prótese Vascular , Curcumina/administração & dosagem , Músculo Liso Vascular/efeitos dos fármacos , Músculo Liso Vascular/fisiologia , Fagócitos/efeitos dos fármacos , Fagócitos/fisiologia , Animais , Materiais Biocompatíveis/química , Adesão Celular/efeitos dos fármacos , Proliferação de Células/efeitos dos fármacos , Curcumina/química , Implantes de Medicamento/administração & dosagem , Regulação da Expressão Gênica/efeitos dos fármacos , Oclusão de Enxerto Vascular/prevenção & controle , Humanos , Masculino , Teste de Materiais , Camundongos , Músculo Liso Vascular/citologia , Fagócitos/citologia , Poliésteres/química , Stents
9.
Med Device Technol ; 15(1): 12-4, 2004.
Artigo em Inglês | MEDLINE | ID: mdl-14994632

RESUMO

Mineral encrustation is a common complication associated with the use of urethral catheters and stents. A pH-controlling coating has been developed to reduce mineral encrustation on device surfaces by preventing the elevation of surface pH. Primary data show that the approach has the potential to reduce encrustation on the molecular level.


Assuntos
Cateteres de Demora , Materiais Revestidos Biocompatíveis/química , Cristalização , Contaminação de Equipamentos/prevenção & controle , Falha de Equipamento , Minerais/química , Stents , Cateterismo Urinário/instrumentação , Adsorção , Cálcio/química , Materiais Revestidos Biocompatíveis/síntese química , Desenho de Equipamento , Análise de Falha de Equipamento , Humanos , Concentração de Íons de Hidrogênio , Magnésio/química , Urina/química
10.
Ann Biomed Eng ; 31(6): 667-77, 2003 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-12797616

RESUMO

A bioresorbable, expandable poly(L-lactic acid) stent has been designed, based on a linear, continuous coil array principle, by which multiple furled lobes convert to a single lobe upon balloon expansion, without heating. Stent strength and compliance are sufficient to permit deployment by a conventional balloon angioplasty catheter. Several multiple lobe configurations were investigated, with expansion ratios ranging from 1.4 to 1.9 and expanded diameters ranging from 2.3 to 4.7 mm. Compression resistance of the expanded stent is dependent on fiber coil density and fiber ply. A range sufficient for endovascular service was obtained, with less than 4% elastic recoil in six day saline incubation studies. Surface plasma treatment with di(ethylene glycol) vinyl ether significantly reduced platelet adhesion in a 1 h porcine arteriovenous shunt model. Patency was maintained in one week implant studies in the porcine common femoral artery. However, a strong inflammatory response, and significant reduction of the vascular lumen were observed following two weeks implantation. The design principles and fabrication techniques for this bioresorbable stent are sufficiently versatile that a broad range of applications can be addressed. Much work remains to be done, including long-term evaluation of the inflammatory response, and of polymer degradation. The results of this study demonstrate the feasibility of expandable biodegradable stent design and deployment by conventional means.


Assuntos
Implantes Absorvíveis , Prótese Vascular/efeitos adversos , Artéria Femoral/patologia , Artéria Femoral/cirurgia , Infecções Relacionadas à Prótese/etiologia , Stents/efeitos adversos , Animais , Pressão Sanguínea , Materiais Revestidos Biocompatíveis/efeitos adversos , Materiais Revestidos Biocompatíveis/síntese química , Elasticidade , Análise de Falha de Equipamento/métodos , Etilenoglicóis/efeitos adversos , Artéria Femoral/fisiopatologia , Ácido Láctico , Movimento (Física) , Ativação Plaquetária , Poliésteres , Polímeros , Desenho de Prótese , Falha de Prótese , Infecções Relacionadas à Prótese/patologia , Suínos , Compostos de Vinila/efeitos adversos
11.
J Biomater Sci Polym Ed ; 14(4): 299-312, 2003.
Artigo em Inglês | MEDLINE | ID: mdl-12747671

RESUMO

Metal stents and, more recently, polymer-coated metal stents are used to stabilize dissections, eliminate vessel recoil, and guide remodeling after balloon angioplasty and other treatments for arterial disease. Bioresorbable polymeric stents are being developed to improve the biocompatibility and the drug reservoir capacity of metal stents, and to offer a transient alternative to the permanent metallic stent implant. Following a brief review of metal stent technology, the emerging class of expandable, bioresorbable polymeric stents is described, with emphasis on developments in the authors' laboratory.


Assuntos
Polímeros , Stents/tendências , Biodegradação Ambiental , Materiais Revestidos Biocompatíveis , Sistemas de Liberação de Medicamentos , Humanos , Implantação de Prótese
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...